Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifestance Health Group ( (LFST) ) has issued an update.
On February 25, 2026, LifeStance Health Group, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC and certain selling stockholders for an underwritten secondary offering of 25,000,000 shares of its common stock, under an existing shelf registration filed in May 2024. All shares were sold by the selling stockholders, and the company did not receive any proceeds from the offering, which closed on March 2, 2026.
As part of the transaction, LifeStance agreed to repurchase 7,000,000 of the offered shares from the underwriter at the same price paid to the selling stockholders, with the underwriter receiving no compensation on the repurchased portion. The deal effectively shifts ownership among existing investors while allowing the company to reduce its public float by the repurchased shares, with legal opinions on the shares provided by Ropes & Gray LLP.
The most recent analyst rating on (LFST) stock is a Buy with a $8.50 price target. To see the full list of analyst forecasts on Lifestance Health Group stock, see the LFST Stock Forecast page.
Spark’s Take on LFST Stock
According to Spark, TipRanks’ AI Analyst, LFST is a Neutral.
LFST scores as moderate: improving fundamentals and upbeat 2026 guidance (growth, margin expansion, and positive free cash flow) are the main positives, supported by a constructive technical uptrend. The biggest offset is valuation risk from an extremely high P/E, with still-thin profitability and execution items (notably EHR transition and clinician competition) limiting the score.
To see Spark’s full report on LFST stock, click here.
More about Lifestance Health Group
LifeStance Health Group, Inc. operates in the behavioral health care industry, providing outpatient mental health services through a network-based model. The company focuses on delivering psychiatric and therapeutic care to patients across the U.S., working with payors and other stakeholders to expand access to mental health treatment.
Average Trading Volume: 2,185,914
Technical Sentiment Signal: Buy
Current Market Cap: $2.82B
Find detailed analytics on LFST stock on TipRanks’ Stock Analysis page.